APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

G-CSF and G-CSF Biosimilars

Compare research editions
View pricing & licenses

Selected research

Industry Research

G-CSF and G-CSF Biosimilars Industry Research Report 2026

Report ID 173993610520 December 2025123 pages

Choose your research edition.

Industry ResearchG-CSF and G-CSF Biosimilars Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal G-CSF and G-CSF Biosimilars Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal G-CSF and G-CSF Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal G-CSF and G-CSF Biosimilars Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal G-CSF and G-CSF Biosimilars Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global G-CSF and G-CSF Biosimilars market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for G-CSF and G-CSF Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for G-CSF and G-CSF Biosimilars is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for G-CSF and G-CSF Biosimilars is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of G-CSF and G-CSF Biosimilars include Sanofi, Johnson & Johnson, Novartis, Merck & Co., Roche, Pfizer, GlaxoSmithKline, Bayer and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global G-CSF and G-CSF Biosimilars market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

G-CSF and G-CSF Biosimilars Market by Company

Sanofi

Johnson & Johnson

Novartis

Merck & Co.

Roche

Pfizer

GlaxoSmithKline

Bayer

Amgen

AbbVie

AstraZeneca

Gilead Science

G-CSF and G-CSF Biosimilars Segment by Type

Chronic And Autoimmune Diseases

Growth Hormone Deficiencies

Blood Disorders

Oncology Diseases

G-CSF and G-CSF Biosimilars Segment by Application

Insulin

Human Growth Hormone

Interferon

Monoclonal Antibodies

Erythropoietin

G-CSF and G-CSF Biosimilars Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global G-CSF and G-CSF Biosimilars market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of G-CSF and G-CSF Biosimilars and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of G-CSF and G-CSF Biosimilars.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of G-CSF and G-CSF Biosimilars manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of G-CSF and G-CSF Biosimilars by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of G-CSF and G-CSF Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global G-CSF and G-CSF Biosimilars Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global G-CSF and G-CSF Biosimilars Sales (K Units) of Manufacturers (2021-2026) Table 7. Global G-CSF and G-CSF Biosimilars Sales Market Share by Manufacturers (2021-2026) Table 8. Global G-CSF and G-CSF Biosimilars Revenue of Manufacturers (2021-2026) Table 9. Global G-CSF and G-CSF Biosimilars Revenue Share by Manufacturers (2021-2026) Table 10. Global Market G-CSF and G-CSF Biosimilars Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global G-CSF and G-CSF Biosimilars Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of G-CSF and G-CSF Biosimilars, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of G-CSF and G-CSF Biosimilars, Product Type & Application Table 14. Global G-CSF and G-CSF Biosimilars Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global G-CSF and G-CSF Biosimilars by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sanofi Company Information Table 19. Sanofi Business Overview Table 20. Sanofi G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Sanofi G-CSF and G-CSF Biosimilars Product Portfolio Table 22. Sanofi Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson G-CSF and G-CSF Biosimilars Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Novartis Company Information Table 29. Novartis Business Overview Table 30. Novartis G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Novartis G-CSF and G-CSF Biosimilars Product Portfolio Table 32. Novartis Recent Developments Table 33. Merck & Co. Company Information Table 34. Merck & Co. Business Overview Table 35. Merck & Co. G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Merck & Co. G-CSF and G-CSF Biosimilars Product Portfolio Table 37. Merck & Co. Recent Developments Table 38. Roche Company Information Table 39. Roche Business Overview Table 40. Roche G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Roche G-CSF and G-CSF Biosimilars Product Portfolio Table 42. Roche Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Pfizer G-CSF and G-CSF Biosimilars Product Portfolio Table 47. Pfizer Recent Developments Table 48. GlaxoSmithKline Company Information Table 49. GlaxoSmithKline Business Overview Table 50. GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Portfolio Table 52. GlaxoSmithKline Recent Developments Table 53. Bayer Company Information Table 54. Bayer Business Overview Table 55. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Bayer G-CSF and G-CSF Biosimilars Product Portfolio Table 57. Bayer Recent Developments Table 58. Amgen Company Information Table 59. Amgen Business Overview Table 60. Amgen G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Amgen G-CSF and G-CSF Biosimilars Product Portfolio Table 62. Amgen Recent Developments Table 63. AbbVie Company Information Table 64. AbbVie Business Overview Table 65. AbbVie G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. AbbVie G-CSF and G-CSF Biosimilars Product Portfolio Table 67. AbbVie Recent Developments Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. AstraZeneca G-CSF and G-CSF Biosimilars Product Portfolio Table 72. AstraZeneca Recent Developments Table 73. Gilead Science Company Information Table 74. Gilead Science Business Overview Table 75. Gilead Science G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Gilead Science G-CSF and G-CSF Biosimilars Product Portfolio Table 77. Gilead Science Recent Developments Table 78. Global G-CSF and G-CSF Biosimilars Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global G-CSF and G-CSF Biosimilars Sales by Region (2021-2026) & (K Units) Table 80. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2021-2026) Table 81. Global G-CSF and G-CSF Biosimilars Sales by Region (2027-2032) & (K Units) Table 82. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2027-2032) Table 83. Global G-CSF and G-CSF Biosimilars Revenue by Region (2021-2026) & (US$ Million) Table 84. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2021-2026) Table 85. Global G-CSF and G-CSF Biosimilars Revenue by Region (2027-2032) & (US$ Million) Table 86. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2027-2032) Table 87. North America G-CSF and G-CSF Biosimilars Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America G-CSF and G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 89. North America G-CSF and G-CSF Biosimilars Sales by Country (2027-2032) & (K Units) Table 90. North America G-CSF and G-CSF Biosimilars Revenue by Country (2021-2026) & (US$ Million) Table 91. North America G-CSF and G-CSF Biosimilars Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe G-CSF and G-CSF Biosimilars Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe G-CSF and G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 94. Europe G-CSF and G-CSF Biosimilars Sales by Country (2027-2032) & (K Units) Table 95. Europe G-CSF and G-CSF Biosimilars Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe G-CSF and G-CSF Biosimilars Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Country (2027-2032) & (US$ Million) Table 102. South America G-CSF and G-CSF Biosimilars Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America G-CSF and G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 104. South America G-CSF and G-CSF Biosimilars Sales by Country (2027-2032) & (K Units) Table 105. South America G-CSF and G-CSF Biosimilars Revenue by Country (2021-2026) & (US$ Million) Table 106. South America G-CSF and G-CSF Biosimilars Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country (2027-2032) & (US$ Million) Table 112. Global G-CSF and G-CSF Biosimilars Sales by Type (2021-2026) & (K Units) Table 113. Global G-CSF and G-CSF Biosimilars Sales by Type (2027-2032) & (K Units) Table 114. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2021-2026) Table 115. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2027-2032) Table 116. Global G-CSF and G-CSF Biosimilars Revenue by Type (2021-2026) & (US$ Million) Table 117. Global G-CSF and G-CSF Biosimilars Revenue by Type (2027-2032) & (US$ Million) Table 118. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2021-2026) Table 119. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2027-2032) Table 120. Global G-CSF and G-CSF Biosimilars Price by Type (2021-2026) & (US$/Unit) Table 121. Global G-CSF and G-CSF Biosimilars Price by Type (2027-2032) & (US$/Unit) Table 122. Global G-CSF and G-CSF Biosimilars Sales by Application (2021-2026) & (K Units) Table 123. Global G-CSF and G-CSF Biosimilars Sales by Application (2027-2032) & (K Units) Table 124. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2021-2026) Table 125. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2027-2032) Table 126. Global G-CSF and G-CSF Biosimilars Revenue by Application (2021-2026) & (US$ Million) Table 127. Global G-CSF and G-CSF Biosimilars Revenue by Application (2027-2032) & (US$ Million) Table 128. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2021-2026) Table 129. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2027-2032) Table 130. Global G-CSF and G-CSF Biosimilars Price by Application (2021-2026) & (US$/Unit) Table 131. Global G-CSF and G-CSF Biosimilars Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. G-CSF and G-CSF Biosimilars Distributors List Table 135. G-CSF and G-CSF Biosimilars Customers List Table 136. G-CSF and G-CSF Biosimilars Industry Trends Table 137. G-CSF and G-CSF Biosimilars Industry Drivers Table 138. G-CSF and G-CSF Biosimilars Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. G-CSF and G-CSF Biosimilars Product Image Figure 5. Global G-CSF and G-CSF Biosimilars Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global G-CSF and G-CSF Biosimilars Market Size (2021-2032) & (US$ Million) Figure 7. Global G-CSF and G-CSF Biosimilars Sales (2021-2032) & (K Units) Figure 8. Global G-CSF and G-CSF Biosimilars Average Price (US$/Unit) & (2021-2032) Figure 9. Chronic And Autoimmune Diseases Product Image Figure 10. Growth Hormone Deficiencies Product Image Figure 11. Blood Disorders Product Image Figure 12. Oncology Diseases Product Image Figure 13. Insulin Product Image Figure 14. Human Growth Hormone Product Image Figure 15. Interferon Product Image Figure 16. Monoclonal Antibodies Product Image Figure 17. Erythropoietin Product Image Figure 18. Global G-CSF and G-CSF Biosimilars Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of G-CSF and G-CSF Biosimilars, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 G-CSF and G-CSF Biosimilars Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global G-CSF and G-CSF Biosimilars Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global G-CSF and G-CSF Biosimilars Sales by Region in 2025 Figure 24. Global G-CSF and G-CSF Biosimilars Revenue by Region in 2025 Figure 25. North America G-CSF and G-CSF Biosimilars Market Size by Country in 2025 Figure 26. North America G-CSF and G-CSF Biosimilars Sales Market Share by Country (2021-2032) Figure 27. North America G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2021-2032) Figure 28. United States G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe G-CSF and G-CSF Biosimilars Market Size by Country in 2025 Figure 31. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Country (2021-2032) Figure 32. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2021-2032) Figure 33. Germany G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Asia Pacific G-CSF and G-CSF Biosimilars Market Size by Country in 2025 Figure 39. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Country (2021-2032) Figure 40. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2021-2032) Figure 41. China G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Japan G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. South Korea G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. India G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Australia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. China Taiwan G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South America G-CSF and G-CSF Biosimilars Market Size by Country in 2025 Figure 50. South America G-CSF and G-CSF Biosimilars Sales Market Share by Country (2021-2032) Figure 51. South America G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2021-2032) Figure 52. Mexico G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Brazil G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Middle East and Africa G-CSF and G-CSF Biosimilars Market Size by Country in 2025 Figure 56. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Country (2021-2032) Figure 57. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2021-2032) Figure 58. Turkey G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Saudi Arabia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. UAE G-CSF and G-CSF Biosimilars Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2021-2032) Figure 62. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2021-2032) Figure 63. Global G-CSF and G-CSF Biosimilars Price (US$/Unit) by Type (2021-2032) Figure 64. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2021-2032) Figure 65. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2021-2032) Figure 66. Global G-CSF and G-CSF Biosimilars Price (US$/Unit) by Application (2021-2032) Figure 67. G-CSF and G-CSF Biosimilars Value Chain Figure 68. G-CSF and G-CSF Biosimilars Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. G-CSF and G-CSF Biosimilars Industry Opportunities and Challenges

Scope & coverage.

Types
  • Chronic And Autoimmune Diseases
  • Growth Hormone Deficiencies
  • Blood Disorders
  • Oncology Diseases
Applications
  • Insulin
  • Human Growth Hormone
  • Interferon
  • Monoclonal Antibodies
  • Erythropoietin
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Gilead Science

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global G-CSF and G-CSF Biosimilars Market Size (2021-2032)
  4. 2.2.2 Global G-CSF and G-CSF Biosimilars Sales (2021-2032)
  5. 2.2.3 Global G-CSF and G-CSF Biosimilars Market Average Price (2021-2032)
  6. 2.3 G-CSF and G-CSF Biosimilars by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Chronic And Autoimmune Diseases
  9. 2.3.3 Growth Hormone Deficiencies
  10. 2.3.4 Blood Disorders
  11. 2.3.5 Oncology Diseases
  12. 2.4 G-CSF and G-CSF Biosimilars by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Insulin
  15. 2.4.3 Human Growth Hormone
  16. 2.4.4 Interferon
  17. 2.4.5 Monoclonal Antibodies
  18. 2.4.6 Erythropoietin
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global G-CSF and G-CSF Biosimilars Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global G-CSF and G-CSF Biosimilars Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global G-CSF and G-CSF Biosimilars Revenue of Manufacturers (2021-2026)
  4. 3.4 Global G-CSF and G-CSF Biosimilars Average Price by Manufacturers (2021-2026)
  5. 3.5 Global G-CSF and G-CSF Biosimilars Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of G-CSF and G-CSF Biosimilars, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of G-CSF and G-CSF Biosimilars, Product Type & Application
  8. 3.8 Global Manufacturers of G-CSF and G-CSF Biosimilars, Established Date
  9. 3.9 Global G-CSF and G-CSF Biosimilars Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sanofi
  2. 4.1.1 Sanofi Company Information
  3. 4.1.2 Sanofi Business Overview
  4. 4.1.3 Sanofi G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sanofi G-CSF and G-CSF Biosimilars Product Portfolio
  6. 4.1.5 Sanofi Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Novartis
  14. 4.3.1 Novartis Company Information
  15. 4.3.2 Novartis Business Overview
  16. 4.3.3 Novartis G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novartis G-CSF and G-CSF Biosimilars Product Portfolio
  18. 4.3.5 Novartis Recent Developments
  19. 4.4 Merck & Co.
  20. 4.4.1 Merck & Co. Company Information
  21. 4.4.2 Merck & Co. Business Overview
  22. 4.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Product Portfolio
  24. 4.4.5 Merck & Co. Recent Developments
  25. 4.5 Roche
  26. 4.5.1 Roche Company Information
  27. 4.5.2 Roche Business Overview
  28. 4.5.3 Roche G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Roche G-CSF and G-CSF Biosimilars Product Portfolio
  30. 4.5.5 Roche Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer G-CSF and G-CSF Biosimilars Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 GlaxoSmithKline
  38. 4.7.1 GlaxoSmithKline Company Information
  39. 4.7.2 GlaxoSmithKline Business Overview
  40. 4.7.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Portfolio
  42. 4.7.5 GlaxoSmithKline Recent Developments
  43. 4.8 Bayer
  44. 4.8.1 Bayer Company Information
  45. 4.8.2 Bayer Business Overview
  46. 4.8.3 Bayer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Bayer G-CSF and G-CSF Biosimilars Product Portfolio
  48. 4.8.5 Bayer Recent Developments
  49. 4.9 Amgen
  50. 4.9.1 Amgen Company Information
  51. 4.9.2 Amgen Business Overview
  52. 4.9.3 Amgen G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Amgen G-CSF and G-CSF Biosimilars Product Portfolio
  54. 4.9.5 Amgen Recent Developments
  55. 4.10 AbbVie
  56. 4.10.1 AbbVie Company Information
  57. 4.10.2 AbbVie Business Overview
  58. 4.10.3 AbbVie G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 AbbVie G-CSF and G-CSF Biosimilars Product Portfolio
  60. 4.10.5 AbbVie Recent Developments
  61. 4.11 AstraZeneca
  62. 4.11.1 AstraZeneca Company Information
  63. 4.11.2 AstraZeneca Business Overview
  64. 4.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 AstraZeneca G-CSF and G-CSF Biosimilars Product Portfolio
  66. 4.11.5 AstraZeneca Recent Developments
  67. 4.12 Gilead Science
  68. 4.12.1 Gilead Science Company Information
  69. 4.12.2 Gilead Science Business Overview
  70. 4.12.3 Gilead Science G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Gilead Science G-CSF and G-CSF Biosimilars Product Portfolio
  72. 4.12.5 Gilead Science Recent Developments
5 Global G-CSF and G-CSF Biosimilars Market Scenario by Region
  1. 5.1 Global G-CSF and G-CSF Biosimilars Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global G-CSF and G-CSF Biosimilars Sales by Region: 2021-2032
  3. 5.2.1 Global G-CSF and G-CSF Biosimilars Sales by Region: 2021-2026
  4. 5.2.2 Global G-CSF and G-CSF Biosimilars Sales by Region: 2027-2032
  5. 5.3 Global G-CSF and G-CSF Biosimilars Revenue by Region: 2021-2032
  6. 5.3.1 Global G-CSF and G-CSF Biosimilars Revenue by Region: 2021-2026
  7. 5.3.2 Global G-CSF and G-CSF Biosimilars Revenue by Region: 2027-2032
  8. 5.4 North America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  9. 5.4.1 North America G-CSF and G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America G-CSF and G-CSF Biosimilars Sales by Country (2021-2032)
  11. 5.4.3 North America G-CSF and G-CSF Biosimilars Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  15. 5.5.1 Europe G-CSF and G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe G-CSF and G-CSF Biosimilars Sales by Country (2021-2032)
  17. 5.5.3 Europe G-CSF and G-CSF Biosimilars Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific G-CSF and G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific G-CSF and G-CSF Biosimilars Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  35. 5.7.1 South America G-CSF and G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America G-CSF and G-CSF Biosimilars Sales by Country (2021-2032)
  37. 5.7.3 South America G-CSF and G-CSF Biosimilars Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa G-CSF and G-CSF Biosimilars Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global G-CSF and G-CSF Biosimilars Sales by Type (2021-2032)
  2. 6.1.1 Global G-CSF and G-CSF Biosimilars Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2021-2032)
  4. 6.2 Global G-CSF and G-CSF Biosimilars Revenue by Type (2021-2032)
  5. 6.2.1 Global G-CSF and G-CSF Biosimilars Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2021-2032)
  7. 6.3 Global G-CSF and G-CSF Biosimilars Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global G-CSF and G-CSF Biosimilars Sales by Application (2021-2032)
  2. 7.1.1 Global G-CSF and G-CSF Biosimilars Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2021-2032)
  4. 7.2 Global G-CSF and G-CSF Biosimilars Revenue by Application (2021-2032)
  5. 7.2.1 Global G-CSF and G-CSF Biosimilars Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2021-2032)
  7. 7.3 Global G-CSF and G-CSF Biosimilars Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 G-CSF and G-CSF Biosimilars Value Chain Analysis
  2. 8.1.1 G-CSF and G-CSF Biosimilars Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 G-CSF and G-CSF Biosimilars Production Mode & Process
  5. 8.2 G-CSF and G-CSF Biosimilars Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 G-CSF and G-CSF Biosimilars Distributors
  8. 8.2.3 G-CSF and G-CSF Biosimilars Customers
9 Global G-CSF and G-CSF Biosimilars Analyzing Market Dynamics
  1. 9.1 G-CSF and G-CSF Biosimilars Industry Trends
  2. 9.2 G-CSF and G-CSF Biosimilars Industry Drivers
  3. 9.3 G-CSF and G-CSF Biosimilars Industry Opportunities and Challenges
  4. 9.4 G-CSF and G-CSF Biosimilars Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst